Press Releases
Stay updated with the latest from BreezeBio
Press Releases
BreezeBio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pipeline Development
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
Announcements
GenEdit Achieves First Milestone from Collaboration and License Agreement with Genentech
Announcements
GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology
Announcements
GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease
Announcements
GenEdit Announces Series A1 Financing
Announcements
GenEdit Is a Phase I Winner of the NIH TARGETED Challenge
Announcements
Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases
Catch Up With
